Vaccines development, regulations and manufacturing Part-2

 

In Part 2, we will review vaccine processes with examples based upon influenza vaccine, inactivated Polio vaccine and an overview of the different types of vaccine production processes from cell expansion, USP and DSP, to the formulation and filling operations to make the finished product. We will talk about vaccine production facilities, how equipment is integrated their operating principles and biological safety levels for containment. Finally, we will look at the vaccine industry today, the supply chain and globalization, and how important vaccines are in pandemic preparedness, availability, and time to market.

Speakers

Stephen W. Brown , PhD

Stephen W. Brown, PhD

 

Consultant

Pall Biotech

 

Stephen is a consultant based in France with 40 years experience in the biopharmaceutical industry. Formerly, he was Executive Director, BE Vaccines, Nantes, France, and IPV Project Champion for the parent company, Biological E Ltd, Hyderabad, India. Steve holds a BSc in Microbiology from University of Cardiff and a PhD in Fermentation Technology from University of Kent at Canterbury, UK. His Postdoctoral was at the Institut für Biotechnologie, ETH Zurich, Switzerland. 

 

Steve’s career has focused on human and animal vaccines and gene medicines product development including, process development, GMP manufacturing, site management, manufacturing facility design and construction, Single-use Technology implementation and exploitation and partnership management. Prior to joining Biological E. Ltd, he previously worked at, G.D Searle (UK) and Transgene, Merial and Vivalis/Valneva (USA/France). Steve is a member of PDA, ISPE and ASTM and joint author of PDA SUS TR66. He was previously a board member of the Bio-Process Systems Alliance and Co-Chair of BPSA's European Advisory Council.

Helene Pora

Helene Pora

 

VP Technical Communication & Regulatory Strategy

Pall Biotech

 

Helene has been instrumental in the development of Pall single-use technologies for the last 20 years, while getting heavily involved in manufacturing, quality and regulatory aspects. She has over 30 years of experience working for the biopharmaceutical industry, the last 29 years within Pall Corporation. She speaks regularly at conferences about single-use technology with a strong focus on validation and overall process integration aspects. She is also involved in different industry interested group with a strong focus on BPOG, and she is sitting on the board of BPSA.

Vaccines development, regulations and manufacturing Part-2

icon image

Vaccine Production: Securing process quality with flexible manufacturing solutions

 Attendees will get a critical look at the vaccine industry today, its globalization and how the cost of a vaccine is assessed. Different types of vaccine production processes, equipment, and activities will be reviewed.

더 Biotech 웨비나
Our webinars keep you informed on the latest products and technologies, current industry topics, the latest trends and a range of innovations and solutions to help continuously improve your processes.
December 2020
Servicios de Validación de Filtración y Single Use Technology

Biotech | Pall Corporation 웨비나 시리즈

¡Todo sobre los ensayos de validaciones para cumplir con los máximos estándares regulatorios!

Hablaremos sobre puntos cruciales de los servicios de validación, incluyendo:

1. Necesidad de validación

2. Cómo se realizan los ensayos de validación

3. Análisis de riesgo: re uso de filtros y toma de decisión en ensayos a realizar

4. Servicio de Validación Pall: documentación requerida para iniciar una cotización

¡No pierdas esta segunda oportunidad!

등록